Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 12.64
-0.14 (-1.10%)
At close: Jan 30, 2026
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
620.46K CHF
Profits / Employee
-829.66K CHF
Market Cap
175.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 79 | 34 | 75.22% |
| Dec 31, 2023 | 45 | -1 | -2.18% |
| Dec 31, 2022 | 46 | 6 | 16.24% |
| Dec 31, 2021 | 39 | -47 | -54.19% |
| Dec 31, 2020 | 86 | -27 | -23.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Basilea Pharmaceutica AG | 180 |
| Molecular Partners AG | 153 |
| BioVersys AG | 29 |
| Newron Pharmaceuticals | 22 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |
Santhera Pharmaceuticals Holding AG News
- 16 days ago - Swissmedic Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy - Nasdaq
- 3 months ago - Half Year 2025 Santhera Pharmaceuticals Holding AG Analyst Briefing Transcript - GuruFocus
- 4 months ago - Santhera Partners With Biomedica To Distribute Agamree In Russia - Nasdaq
- 4 months ago - Health Canada Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy - Nasdaq
- 4 months ago - Santhera Pharmaceuticals Holding AG (SPHDF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Santhera Pharmaceuticals Holding AG 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Santhera Pharma Stock Down On Wider H1 Loss; Is AGAMREE On Track? - Nasdaq
- 5 months ago - Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India - GlobeNewsWire